Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway

Fig. 6

CD58 activates the Wnt/β-catenin signaling pathway in HCC cells. a The association between CD58 and β-catenin from the TCGA database. b TOP luciferase activity assay revealed the effect of CD58 silencing on TCF/LEF-mediated transcription activity. c Western blotting analysis of the levels of CD58, total β-catenin, active β-catenin (S33/37/T41), Cyclin D1, and c-Myc protein (n = 3). d Immunofluorescence analysis of the localization of active β-catenin. e A subcellular fractionation assay was performed to isolate the nuclear and cytoplasmic fractions and evaluated the expression of active and total β-catenin (n = 2)

Back to article page